CoChat

Comorbidities associated with ­vitiligo: a ten-year retrospective study

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Background: Vitiligo is a common disorder of depigmentation that has been associated with other autoimmune diseases. No recent large-scale data exist on the rates of comorbidities associated with vitiligo from the United States population. Objectives: To identify the prevalence of comorbidities as well as associated laboratory abnormalities in vitiligo patients. Methods: All medical records dating from January 1, 2000 to June 21, 2011 within the Research Patient Data Repository were evaluated retrospectively using a novel artificial intelligence-based computer program. A total of 3,280 patients carrying the diagnosis of vitiligo were identified using ICD-9 code 709.01. We randomly selected 300 patients and validated the diagnosis by manually reviewing their medical records. These results were used to create a model that was then applied to the larger set yielding 2,441 true vitiligo patients. 1,657 (68%) were diagnosed by dermatologists and 784 (32%) by non-dermatologists. We identified the prevalence of other comorbid autoimmune conditions by searching problem lists of vitiligo patients and collected laboratory data from the first available data point in the system for each patient. Results: Women were more frequently represented (57.6%) than men (42.4%). The majority of vitiligo patients were White/Caucasian (56.9%), followed by Hispanic/Latino (19.4%). 565 (23%) had one of the following comorbidities: 287 thyroid-related, 186 psoriasis, 72 rheumatoid arthritis, 59 alopecia areata, 55 inflammatory bowel disease, 53 systemic lupus and 20 type I diabetes mellitus. 41% had elevated anti-nuclear antibody levels. Almost half of the patients tested had elevated thyroid peroxidase antibodies. Over 50% of the patients tested had low or insufficient levels of 25-OH vitamin D. Conclusion: We found a high prevalence of comorbidities among individuals with vitiligo presenting to teaching hospitals in Boston, Mass. Comorbid autoimmune conditions were seen in 23% of vitiligo patients, thyroid disorders and psoriasis being the most common. Screening for these conditions, especially thyroid disorders, should be considered in vitiligo patients.

Overview

Integrity signals

Registry

Crossref · 10.1159/000354607

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 17 references

Cited by

See all 147

Metadata

Authors
Sheth, V. M., Guo, Y., & Qureshi, A. A.
Affiliations
Brigham and Women's Hospital (US)
Venue
Dermatology
Publisher
S. Karger AG
Published
2013
Volume
227
Issue
4
Pages
311-315
ISSN
  • 1018-8665 (ISSN-L)
  • 1421-9832
OpenAlex
W2054293537
Cited by
128
References
17
Citations by year
2026: 8 · 2025: 5 · 2024: 13 · 2023: 19 · 2022: 10 · 2021: 12 · 2020: 11 · 2019: 9 · 2018: 4 · 2017: 12 · 2016: 10 · 2015: 10 · 2014: 5
FWCI
4.83
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Hair Growth and Disorders
Keywords
vitiligo, comorbidities, autoimmune disease, thyroid dysfunction, psoriasis, rheumatoid arthritis, alopecia areata, inflammatory bowel disease, systemic lupus erythematosus, type 1 diabetes, antinuclear antibodies, thyroid peroxidase antibodies, vitamin D deficiency, prevalence, screening
MeSH terms
Alopecia Areata, Antibodies, Antinuclear, Arthritis, Rheumatoid, Boston, Diabetes Mellitus, Type 1, Female, Humans, Iodide Peroxidase, Lupus Erythematosus, Systemic, Male, Middle Aged, Psoriasis, Retrospective Studies, Sex Factors, Thyroid Diseases, Vitamin D, Vitiligo, Inflammatory Bowel Diseases, Comorbidity, Prevalence, Racial Groups

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comorbidities associated with ­vitiligo: a ten-year retrospective study. https://app.cochat.ai/papers/10.1159/000354607
The paper
Sheth, V. M., Guo, Y., & Qureshi, A. A. (2013). Comorbidities associated with ­vitiligo: a ten-year retrospective study. Dermatology. https://doi.org/10.1159/000354607

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.